Learning from the 2012-2013 class of breakthrough therapies.

The article offers information on the approval of drugs involved in breakthrough therapies of global pharmaceutical companies including F. Hoffmann-La Roche Ltd., Vertex Pharmaceuticals Inc. and Genentech Inc., by the U.S. Food and Drug Administration (FDA) as of December 2013. It mentions the table which lists several drugs approved by the FDA along with their target for cancer treatment. An overview of clinical trial status for the treatment of cystic fibrosis and cancer is presented.